Phibro Animal Health Corporation is a drug manufacturers - specialty & generic business based in the US. Phibro Animal Health Corporation shares (PAHC) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $40.15 – . Phibro Animal Health Corporation employs 2,475 staff and has a trailing 12-month revenue of around $1.4 billion.
Probability of Member receiving $1,000 is a probability of 0.026%; If you don’t make a selection in 45 days, you’ll no longer qualify for the promo. Customer must fund their account with a minimum of $50.00 to qualify. Probability percentage is subject to decrease.
Terms and conditions apply*. For 401k rollovers, existing SoFi IRA members must complete 401k rollovers via this link For SoFi members without a SoFi IRA, a SoFi IRA must first be opened, and 401k rollover must be completed utilizing Capitalize via this link. SoFi and Capitalize will charge no additional fees to process a 401(k) rollover to a SoFi IRA. SoFi is not liable for any costs incurred from the existing 401k provider for rollover. Please check with your 401k provider for any fees or costs associated with the rollover. For IRA contributions, only deposits made via ACH and cash transfer from SoFi Bank accounts are eligible for the match. Click here for the 1% Match terms and conditions.
Trade stocks, ETFs, options, futures and bonds all in one place
$0 commissions on stocks, ETFs and equity options, with low contract fees
Deposit or transfer $10,000+ to earn a 2% Match Bonus. Plus: Get a $100 transfer fee reimbursement on your first brokerage transfer of $2,000 or more. T&C apply.
The Finder Score crunches 147 key metrics we collected directly from 18+ brokers and assessed each provider’s performance based on nine different categories, weighing each metric based on the expertise and insights of Finder’s investment experts. We then scored and ranked each provider to determine the best brokerage accounts.
We update our best picks as products change, disappear or emerge in the market. We also regularly review and revise our selections to ensure our best provider lists reflect the most competitive available.
Paid non-client promotion. Finder does not invest money with providers on this page. If a brand is a referral partner, we're paid when you click or tap through to, open an account with or provide your contact information to the provider. Partnerships are not a recommendation for you to invest with any one company. Learn more about how we make money.
Finder is not an advisor or brokerage service. Information on this page is for educational purposes only and not a recommendation to invest with any one company, trade specific stocks or fund specific investments. All editorial opinions are our own.
Phibro Animal Health Corporation stock price (NASDAQ: PAHC)
Use our graph to track the performance of PAHC stocks over time.
Phibro Animal Health Corporation shares at a glance
Is it a good time to buy Phibro Animal Health Corporation stock?
The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.
This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.
Phibro Animal Health Corporation price performance over time
Historical closes compared with the close of $39.16 from 2025-12-05
1 week (2025-12-05)
39.16
1 month (2025-11-14)
-13.17%
3 months (2025-09-12)
-1.16%
6 months (2025-06-13)
63.64%
1 year (2024-12-13)
72.74%
2 years (2023-12-14)
247.39%
3 years (2022-12-14)
217.55%
5 years (2020-12-14)
143.89%
Is Phibro Animal Health Corporation stock undervalued or overvalued?
Valuing Phibro Animal Health Corporation stock is incredibly difficult, and any metric has to be viewed as part of a bigger picture of Phibro Animal Health Corporation's overall performance. However, analysts commonly use some key metrics to help gauge the value of a stock.
Phibro Animal Health Corporation's P/E ratio
Phibro Animal Health Corporation's current share price divided by its per-share earnings (EPS) over a 12-month period gives a "trailing price/earnings ratio" of roughly 24x. In other words, Phibro Animal Health Corporation shares trade at around 24x recent earnings.
That's relatively low compared to, say, the trailing 12-month P/E ratio for the NASDAQ 100 at the end of 2019 (27.29). The low P/E ratio could mean that investors are pessimistic about the outlook for the shares or simply that they're under-valued.
Phibro Animal Health Corporation's PEG ratio
Phibro Animal Health Corporation's "price/earnings-to-growth ratio" can be calculated by dividing its P/E ratio by its growth – to give 1.6618. A low ratio can be interpreted as meaning the shares offer better value, while a higher ratio can be interpreted as meaning the shares offer worse value.
The PEG ratio provides a broader view than just the P/E ratio, as it gives more insight into Phibro Animal Health Corporation's future profitability. By accounting for growth, it could also help you if you're comparing the share prices of multiple high-growth companies.
Phibro Animal Health Corporation's EBITDA
Phibro Animal Health Corporation's EBITDA (earnings before interest, taxes, depreciation and amortisation) is $209 million.
The EBITDA is a measure of a Phibro Animal Health Corporation's overall financial performance and is widely used to measure a its profitability.
Phibro Animal Health Corporation financials
Revenue TTM
$1.4 billion
Operating margin TTM
13.42%
Gross profit TTM
$443 million
Return on assets TTM
8.55%
Return on equity TTM
23.79%
Profit margin
4.84%
Book value
$7.69
Market Capitalization
$1.6 billion
TTM: trailing 12 months
Phibro Animal Health Corporation share dividends
Dividend payout ratio: 19.43% of net profits
Recently Phibro Animal Health Corporation has paid out, on average, around 0% of net profits as dividends. That has enabled analysts to estimate a "forward annual dividend yield" of 0% of the current stock value. This means that over a year, based on recent payouts (which are sadly no guarantee of future payouts), Phibro Animal Health Corporation shareholders could enjoy a 0% return on their shares, in the form of dividend payments. In Phibro Animal Health Corporation's case, that would currently equate to about $0.48 per share.
While Phibro Animal Health Corporation's payout ratio might seem low, this can signify that Phibro Animal Health Corporation is investing more in its future growth.
Phibro Animal Health Corporation's most recent dividend payout was on 16 December 2025. The latest dividend was paid out to all shareholders who bought their shares by 25 November 2025 (the "ex-dividend date").
Phibro Animal Health Corporation share price volatility
Over the last 12 months, Phibro Animal Health Corporation's shares have ranged in value from as little as $15.9843 up to $46.2943. A popular way to gauge a stock's volatility is its "beta".
Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Phibro Animal Health Corporation's is 0.767. This would suggest that Phibro Animal Health Corporation's shares are less volatile than average (for this exchange).
Phibro Animal Health Corporation overview
Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Latin America and Canada, Europe, the Middle East, Africa, and the Asia Pacific. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs. It also offers animal health products, such as antibacterials, anticoccidials, nutritional specialty, and vaccines and vaccine adjuvants for animal's health and performance, food safety, and animal welfare; and engages in developing, manufacturing, and marketing of microbial and bioproducts for various applications serving animal health and nutrition, environmental, industrial, and agricultural customers. In addition, the company develops, manufactures, and markets conventionally licensed and autogenous vaccine products, as well as adjuvants for animal vaccine manufacturers. Further, it provides formulations and concentrations of trace minerals, such as zinc, copper, manganese, iron, and other compounds to fortify the daily feed requirements of their livestock's diets and maintain optimal balance of trace elements in animals. Additionally, the company offers specialty ingredients for use in personal care, industrial chemical, and chemical catalyst industries.
Frequently asked questions
What percentage of Phibro Animal Health Corporation is owned by insiders or institutions? Currently 0.759% of Phibro Animal Health Corporation shares are held by insiders and 99.897% by institutions.How many people work for Phibro Animal Health Corporation? Latest data suggests 2,475 work at Phibro Animal Health Corporation.When does the fiscal year end for Phibro Animal Health Corporation? Phibro Animal Health Corporation's fiscal year ends in June.Where is Phibro Animal Health Corporation based? Phibro Animal Health Corporation's address is: Glenpointe Centre East, Teaneck, NJ, United States, 07666-6712What is Phibro Animal Health Corporation's ISIN number? Phibro Animal Health Corporation's international securities identification number is: US71742Q1067What is Phibro Animal Health Corporation's CUSIP number? Phibro Animal Health Corporation's Committee on Uniform Securities Identification Procedures number is: 71742Q106
Discover the best stock picking services based on expert analysis, pricing, and strategy fit. Compare top tools to find the right service for your investing style in 2025.
A deep dive into the highlights and limitations of Robinhood.
Advertiser disclosure
Finder.com is an independent comparison platform and information service that aims to provide you with the tools you need to make better decisions. While we are independent, the offers that appear on this site are from companies from which Finder receives compensation. We may receive compensation from our partners for placement of their products or services. We may also receive compensation if you click on certain links posted on our site. While compensation arrangements may affect the order, position or placement of product information, it doesn't influence our assessment of those products. Please don't interpret the order in which products appear on our Site as any endorsement or recommendation from us. Finder compares a wide range of products, providers and services but we don't provide information on all available products, providers or services. Please appreciate that there may be other options available to you than the products, providers or services covered by our service.
We update our data regularly, but information can change between updates. Confirm details with the provider you're interested in before making a decision.
How likely would you be to recommend Finder to a friend or colleague?
0
1
2
3
4
5
6
7
8
9
10
Very UnlikelyExtremely Likely
Required
Thank you for your feedback.
Our goal is to create the best possible product, and your thoughts, ideas and suggestions play a major role in helping us identify opportunities to improve.